Home
Conditions
Gastroesophageal Junction Adenocarcinoma

Clinical trial condition

Gastroesophageal Junction Adenocarcinoma

Explore clinical trials studying Gastroesophageal Junction Adenocarcinoma. Study availability and eligibility vary by location and protocol.

138 public trials 41 recruiting studies

Refine in advanced search Browse all conditions

Gastroesophageal Junction Adenocarcinoma trial results

Not yet recruiting

Mannatide Combined With CAPOX and Tislelizumab for Advanced Gastric Cancer.

NCT07655661

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastric Adenocarcinoma, +7 more
Locations: West China Hospital of Sichuan University Chengdu, Sichuan, China

View Trial Details

Not yet recruiting

Neoadjuvant Intra-tumoral RP2 and FLOT in Gastroesophageal Adenocarcinoma

NCT07059611

Conditions: Adenocarcinoma Of Esophagus, Esophageal Adenocarcinoma, Gastric Adenocarcinoma, +1 more
Locations: Abramson Cancer Center at the University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Not yet recruiting

SKB315 in Combination Therapy in Patients With Advanced or Metastatic GC/ GEJ Adenocarcinoma

NCT07609667

Conditions: Gastroesophageal Junction Adenocarcinoma
Locations: Peking Union Medical College Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China

View Trial Details

Not yet recruiting

Adaptive Adjuvant Therapy After Neoadjuvant Therapy and Gastrectomy for Gastric or Gastroesophageal Junction Adenocarcinoma

NCT07603349

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastric Adenocarcinoma, +7 more
Locations: Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China

View Trial Details

Not yet recruiting

A Clinical Study of Iparomlimab and Tuvonralimab Combined With SOX Following Heterogeneous Radiotherapy as First-line Treatment for Unresectable Locally Advanced or Metastatic HER2-negative Gastric or Gastroesophageal Junction Adenocarcinoma

NCT07502027

Conditions: Digestive System Diseases, Digestive System Neoplasms, Disease, +11 more
Locations: Not specified

View Trial Details

Not yet recruiting

Study of ACC-1898 in Adult Participants With Advanced Solid Tumors

NCT07252661

Conditions: Adenocarcinoma, Advanced Solid Tumor, Biliary Tract Diseases, +44 more
Locations: Not specified

View Trial Details

Not yet recruiting

The Efficacy and Safety of Iparomlimab/Tuvonralimab (Anti PD-1/CTLA-4) Combined With Albumin-bound Paclitaxel in Second-line Treatment of Patients With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

NCT07139587

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +7 more
Locations: Hebei General Hospital Shijiazhuang, Hebei, China

View Trial Details

Not yet recruiting

MAIC of Fruquintinib Plus Paclitaxel Versus Ramucirumab Plus Paclitaxel in Advanced G/GEJ Adenocarcinoma

NCT07144995

Conditions: Advanced Gastric Cancer, Fruquintinib, Gastroesophageal Junction Adenocarcinoma, +1 more
Locations: Not specified

View Trial Details

Not yet recruiting

Combination of QLS31905, QL2107 and Chemotherapy as First-line Therapy in CLDN18.2-positive Unresectable Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

NCT06942767

Conditions: Adenocarcinoma, Carcinoma, Gastric Adenocarcinoma, +4 more
Locations: Not specified

View Trial Details

Not yet recruiting

Postoperative Adjuvant Therapy for CT041 Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma Patients

NCT06857786

Conditions: Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

Beijing Gaobo Hospital Beijing, Beijing Municipality, China

Nanjing Gulou Hospital Nanjing, Jiangsu, China

View Trial Details

Gastroesophageal Junction Adenocarcinoma

Gastroesophageal Junction Adenocarcinoma trial results

Related conditions